The LLCFC1 Polyclonal Antibody (PAC038742) is a versatile research tool designed for the study of CD300A, a cell surface molecule involved in immune regulation. This antibody, produced in rabbits, is highly specific to human samples and has been validated for use in Western blot applications. By binding to the CD300A protein, this antibody allows for the efficient detection and analysis of CD300A in various cell types, making it well-suited for research in immunology and cancer studies.CD300A functions as an immune inhibitory receptor, playing a crucial role in regulating immune responses and maintaining immune homeostasis. Its role in modulating inflammation and inhibiting allergic reactions underscores its importance in understanding diseases such as cancer, autoimmune disorders, and chronic inflammatory conditions.
Research on CD300A activity is vital for the development of innovative therapies that target or manipulate immune function in these disease contexts.In conclusion, the LLCFC1 Polyclonal Antibody is a valuable tool for researchers studying CD300A and its role in immune regulation. Its high reactivity with human samples and suitability for Western blot applications make it an essential component for studies focused on immunology and cancer research.
Western blot. All lanes: LLCFC1 antibody at 3.5µg/ml + K562 whole cell lysate. Secondary. Goat polyclonal to rabbit IgG at 1/10000 dilution. Predicted band size: 14, 5, 17 kDa. Observed band size: 17 kDa.
Immunohistochemistry of paraffin-embedded human small intestine tissue using PACO38742 at dilution of 1:100.
Immunohistochemistry of paraffin-embedded human liver cancer using PACO38742 at dilution of 1:100.
Synonyms:
LLLL and CFNLAS motif-containing protein 1 (MSSP-binding protein CTM-1), LLCFC1, C7orf34
UniProt Protein Function:
C7orf34: 2 isoforms of the human protein are produced by alternative splicing.Protein type: Secreted, signal peptide; SecretedChromosomal Location of Human Ortholog: 7q34Cellular Component: extracellular region
